Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • jsblvbjb jsblvbjb Mar 28, 2013 11:57 AM Flag

    Gaining orphan status increases the likelihood...

    Of accellerated approval from the FDA under the new GAIN act, IMO. I'm expecting positive clinical results that warrant this fast approval, and the great possibility of revenues beginning in 2014 not only for CF internationally, but also NTM right here in the US. What happens if WS starts valuing INSM based on a multiple of next years potential "earnings?" I know I'm jumping the gun here, but if you want to profit, you have to beat the crowd or else get left the crumbs.
    pianoman

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
23.45-1.14(-4.64%)Jun 29 4:00 PMEDT